Introduction The clinical management of Obstructive Hypertrophic Cardiomyopathy remains challenging, and the phase III ...
AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental new drug application (sNDA) for the combination regimen of VENCLEXTA® (venetoclax) and ...
Commercial adoption of the Galleri multi-cancer early detection test remained a bright spot, with more than 185,000 tests ...
Key opportunities in the pancreatic cancer market include advancing novel therapies such as masitinib, pamrevlumab, and quemliclustat, alongside strategic collaborations and FDA designations to foster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results